Stock Research: Steris

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

Steris

NYQ:STE IE00BFY8C754
85
  • Value
    39
  • Growth
    60
  • Safety
    Safety
    87
  • Combined
    67
  • Sentiment
    89
  • 360° View
    360° View
    85
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

STERIS Plc provides products and services focused on infection prevention. It operates in Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The company serves healthcare providers worldwide, medical device and pharmaceutical manufacturers globally, and biopharmaceutical and medical device research and manufacturing facilities. In the last fiscal year, the company had a market cap of $22,511 million, profits of $2,403 million, revenue of $5,460 million, and 17,787 employees.

more

ANALYSIS: With an Obermatt 360° View of 85 (better than 85% compared with alternatives) for 2026, overall professional sentiment and financial characteristics for the stock Steris are very positive. The 360° View is based on consolidating four consolidated indicators, with all but one indicator above average for Steris. The consolidated Growth Rank has a good rank of 60, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. This means that growth is higher than for 60% of competitors in the same industry. The consolidated Safety Rank at 87 means that the company has a financing structure that is safer than 87% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. Finally, the consolidated Sentiment Rank has a good rank of 89, which means that professional investors are more optimistic about the stock than for 89% of alternative investment opportunities. But the consolidated Value Rank is less desirable at 39, meaning that the share price of Steris is on the higher side compared with indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 61% of alternative stocks in the same industry. ...read more

more
Index
D.J. US Health Care
D.J. US Medical Equipment
S&P 500
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 13-Mar-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
39 22 29 43
Growth
60 76 87 67
Safety
Safety
87 26 15 41
Sentiment
89 40 63 87
360° View
360° View
85 28 53 75
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
33 65 78 90
Opinions Change
50 23 29 50
Pro Holdings
n/a 65 64 86
Market Pulse
74 21 42 24
Sentiment
89 40 63 87
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
39 22 29 43
Growth
60 76 87 67
Safety Safety
87 26 15 41
Combined
67 23 25 49
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
35 23 28 33
Price vs. Earnings (P/E)
15 41 42 36
Price vs. Book (P/B)
33 34 34 56
Dividend Yield
67 39 40 42
Value
39 22 29 43
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
59 45 55 56
Profit Growth
92 36 57 58
Capital Growth
26 89 62 51
Stock Returns
45 60 83 63
Growth
60 76 87 67
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
62 36 38 52
Refinancing
60 17 33 35
Liquidity
89 42 30 47
Safety Safety
87 26 15 41

Similar Stocks

Discover high‑ranked alternatives to Steris and broaden your portfolio horizons.

Drägerwerk

GER:DRW8
Country: Germany
Industry: Health Care Equipment
Size: Large
Full Stock Analysis

Glenveagh Properties

ISE:GVR
Country: Ireland
Industry: Homebuilding
Size: Medium
Full Stock Analysis

Alcon

VTX:ALC
Country: Switzerland
Industry: Health Care Supplies
Size: X-Large
Full Stock Analysis

bioMerieux

PAR:BIM
Country: France
Industry: Health Care Equipment
Size: Large
Full Stock Analysis

Frequently Asked
Questions

This stock offers a high growth opportunity with safe financing and positive sentiment. It is typically expensive (low Value Rank), as investors pay a premium for high performance. It is for growth-focused investors comfortable paying a premium for a stock with strong future momentum.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: